Review & Outlook

The high stakes in Trump’s Twitter spat with Islamabad.

The Steele dossier hit men now claim to be political victims.

Why Trump’s approval is so low despite his first-year successes.

Like Mariah Carey, medical device tax has a second act.

Trump puts America on the side of the people, not the Ayatollahs.

Justice and the FBI continue to flout House subpoenas.

Remember all those progressive predictions of looming fascism?

The U.S. uses its leverage for once to force budget reforms..

A case study in how far Detroit will go to punish charter-school students.

Medical advances are accelerating, and even the FDA approves.

Six months later, the Dakota Access Pipeline proves its value.

Demonstrations spread against the regime and its imperial adventures.

Will the U.S. concede a strategic victory to Russia and Iran?

Sorry, Governor, the ‘double taxation’ in New York is yours.

Interior reverses an Obama rule punishing accidental bird killings.

A judge rules that a prosecutor investigating Iran was murdered.

Another rebuke to climate change rule by executive diktat.

The search giant works with hotels to hurt travel competition.

The Kremlin fears Alexei Navalny is too popular, bars his candidacy.

Betsy DeVos shuts down an Obama-era invitation to fraud.

These longstanding residents are valuable assets to the U.S.

Russia is unhappy the U.S. is selling antitank weapons to Kiev.

The philanthropy lobby wins big but still trashes tax reform.

Reining in regulation is a major success of Trump’s first year.

The Journal’s Christmas editorial, published annually since 1949.